The global softgel capsules market size is estimated to reach USD 13.10 billion at a CAGR of 7.9% duriing forecast period 2022-2030
Softgel Capsule Market is predicted to attain a valuation of USD 11.05 Billion while expanding at a CAGR of 5.3% during the forecast term from 2022 to 2030, evaluates Market Research Future (MRFR). The soft gel capsules are a type of capsule that generally utilizes oral drug administration. These capsules utilize the materials such as gelatine, pullulan, potato starch, and pectin for the elasticity and firmness of the outer body. These capsules are efficient in protecting the contents and help in better absorption after oral administration. They are cost-efficient and compatible with various formulations. Such factors are propelling the pharmaceutical industries to adopt them in manufacturing medicines. The advent of advanced manufacturing technologies is accelerating the overall growth of the soft gel capsule industry.
COVID-19 has created huge distress across the manufacturing industries and commercial sectors including various domains of the health care sector. Therefore the soft gel capsules industry has also faced a sharp decline in the year 2020, especially the vegetarian capsule segment, which is due to the economic decline and the disrupted supply chain and production capacities.
However, the demand for nutrition and bioscience was increasing among the potential customers, even though there was a decrease in revenue of about 5.2% in that sector. The easy availability of gelatin-based capsules has reduced the market sales of vegetarian capsules during the pandemic. On the other hand, the demand for vitamin and health supplements was increasing during the pandemic due to the lifestyle change of a huge population. Therefore the growth of the soft gel capsules had witnessed a balanced growth rate.
The increasing number of serious health-related conditions such as cardiovascular diseases, and chronic illness has propelled the overall growth of the soft gel capsule industry in recent times.
The developers and pharmaceutical industries were actively focusing on the development of soft gel capsules by bringing in various varieties to cater to the increasing demand for vitamin supplements and nutrient supplements. Such factors are considered the major drivers of soft gel capsule market growth. Moreover, the key features such as these capsules are manufactured free from modified sugars and obtained from plant-based sources are further propelling the overall growth of the soft gel capsule industry.
The advent of advanced technologies in the soft gel industries and the elimination of modified sugars in their manufacturing has propelled potential customers towards these products, since modified sugars can seriously affect the sugar stability for some patients, this factor is presenting lucrative opportunities for the overall growth of soft gel capsule industry during the forecast period.
The increasing number of clinical trials and the rapid manufacturing of drugs and capsules and the growing demand because of the ailments are presenting favorable conditions for the growth of the soft gel capsule industry during the forecast period. Moreover, the higher investment in the R and D activities are also presenting favorable conditions for the growth of the soft gel capsule industry during the forecast period.
Softgel Capsule Market restraints:
The patent expiration and the issues related to patents and the development of generics are considered the major restraints of the soft gel capsule industry.
The requirement of higher capital for the production of these soft gel capsules due to the highly beneficiary properties and specific packaging is considered the major restraint of soft gel capsules market growth.
Softgel Capsule Market challenges:
The complex processing method and requirement of advanced technologies for the manufacturing and thereafter require a complete cycle during the production process. Such factors are considered the key challenge for the overall growth of the soft gel capsule industry.
The contents specific nature of these soft gels restricts their usage across the pharmaceutical industry. For example, these soft gel capsules cannot be utilized for moisture-sensitive drugs, and thereby they are manufactured using the hard capsule format or tablets.
The animal-based capsules are richly sourced in proteins and offer other benefits such as easier digestion, tamper resistance, supreme mechanical resistance, and supreme seal quality. Moreover, the manufacturers are involved in developing unique capsules where they combine bovine and porcine gelatine to offer higher firmness, plasticity, and clarity to the capsules. Such features increase the quality of the capsules and give a more aesthetic look for them, hence helping in gaining more revenue.
On the other hand, the prevalence of veganism across the globe has stimulated the demand for non-animal-based capsules and thereby propelling the overall growth of the soft gel capsules industry across the globe. Post-COVID, a large population has shifted towards veganism and has strictly avoided animal-based products, such factors have propelled the demand for vegetarian-based capsules in recent times.
The growth of the soft gel capsules industry is increasing in recent times, due to the customer preferences for a healthy lifestyle and increasing awareness of healthy lifestyle and preventive measures. Therefore a huge population has adopted vitamins and dietary supplements in the form of soft gel capsules and registered about 26.3% growth percentage concerning the vitamins and supplements. The benefits of manufacturing these supplements and vitamins in the form of soft gel capsules are that they don’t get oxidized easily and they significantly improve the shelf life of the product. The pharmaceutical industries are proclaiming that soft gel capsules are the idle choice as they help in better and quicker absorption of the contents for humans and they effectively protect the contents, especially vitamins from UV radiation and oxidation.
Based on type:
Based on application:
Based on manufacturers:
Currently, North America is holding the leading market value in the soft gel industry with a exponential growth and is expected to maintain the leading position during the forecast period. The presence of leading and established market players and the higher investment from these established market players combined with the rapid R and D activities across the industry are widening the portfolio and thereby propelling the overall growth of the soft gel capsule industry across North America. Moreover, the awareness related to health and knowledge related to health is increasing through various mediums and the internet. The pharmacy leaders are also working towards the commercialization of the capsules and thereby presenting lucrative opportunities for the overall growth of the soft gel capsule industry during the forecast period.
On the other hand, the Asia-pacific region is also considered the fast-growing market. Moreover, several equipped market players are emerging in recent times across China and India, bringing in cost-effective therapeutics, and beneficiary contracts. Moreover, the leading market players are bringing in personalized medicine expenditure and the high-tech processing techniques are propelling soft gel capsule market growth in recent times.
In the year 2020, one of the leading market players, Catalent Inc had added to products in its portfolio. The Optishell is one of those products, which is manufactured using seaweeds instead of gelatine and they are considered the best option for the vegans.
In the year 2019, one of the leading market players, Ayanda which is considered the established provider of pharmaceutical products have gotten a patent from European legislation for their product. This patent has enabled their product with enhanced features over their probiotic capabilities, powder sticks, hard capsules, and others.
This report has covered:
|Market Size||USD 11.05 Billion|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Application and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Weihai Baihe Biology Technological Co. Ltd., Patheon (part of thermo fisher scientific), Catalent, Inc., Captek softgel International Inc., Capsugel (a part of lonza), Amway, EuroCaps Ltd. (part of the DCC plc Group), Strides Pharma Science Limited, Sirio Pharma Co. Ltd., Soft Gel Technologies, Inc., International Vitamin Corporation|
|Key Market Opportunities||Adoption of Latest Technologies to Offer Lucrative Opportunities in the Forecast Tenure|
|Key Market Drivers||Expanding Health Conscious Population to Boost the Market Growth during the Analysis Tenure|
The global softgel capsule market is expected to reach a valuation of USD 11.05 billion by 2030.
The global softgel capsule market is expected to rise at a solid 5.3% CAGR over the forecast period from 2022 to 2030.
The increasing consumption of nutritional supplements is likely to be the major driver for the global softgel capsule market over the forecast period.
North America holds the largest share in the global softgel capsule market.
Leading players in the softgel capsule market include Patheon, Catalent Inc., Weihai Baihe Biology Technological Co. Ltd., Captek Softgel International Inc., Capsugel, Amway, Strides Pharma Science Limited, Soft Gel Technologies Inc., and International Vitamin Corporation, among others.